These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38421234)

  • 41. Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine.
    Tsuji D; Saito Y; Mushiroda T; Miura M; Hira D; Terada T
    J Clin Pharm Ther; 2021 Jun; 46(3):649-657. PubMed ID: 33555613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Slomp C; Morris E; Edwards L; Hoens AM; Landry G; Riches L; Ridgway L; Bryan S; Austin J
    Can J Psychiatry; 2023 Jun; 68(6):436-452. PubMed ID: 36437757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the pediatric pharmacist in personalized medicine and clinical pharmacogenomics for children: pediatric pharmacogenomics working group.
    Kennedy MJ; Phan H; Benavides S; Potts A; Sorensen S
    J Pediatr Pharmacol Ther; 2011 Apr; 16(2):118-22. PubMed ID: 22477836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Collaborative Counseling Considerations for Pharmacogenomic Tests.
    Zierhut HA; Campbell CA; Mitchell AG; Lemke AA; Mills R; Bishop JR
    Pharmacotherapy; 2017 Sep; 37(9):990-999. PubMed ID: 28672074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis.
    Reid P; Danahey K; Lopez Velazquez M; Ratain MJ; O'Donnell PH
    Clin Exp Rheumatol; 2021; 39(6):1385-1393. PubMed ID: 33506753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.
    Albassam A; Alshammari S; Ouda G; Koshy S; Awad A
    PLoS One; 2018; 13(9):e0203033. PubMed ID: 30183746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
    Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
    J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
    Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
    Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
    Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice.
    Petit C; Croisetière A; Chen F; Laverdière I
    Pharmacogenomics; 2020 Mar; 21(4):247-256. PubMed ID: 32180495
    [No Abstract]   [Full Text] [Related]  

  • 51. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
    Brandl E; Halford Z; Clark MD; Herndon C
    Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression.
    Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF
    Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are Community Pharmacists Ready to Deliver Pharmacogenomics Testing Services?
    Ghazal H; Tahar A; Mason T
    Pharmacy (Basel); 2023 Oct; 11(6):. PubMed ID: 37987380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Tayeh MK; Gaedigk A; Goetz MP; Klein TE; Lyon E; McMillin GA; Rentas S; Shinawi M; Pratt VM; Scott SA;
    Genet Med; 2022 Apr; 24(4):759-768. PubMed ID: 35177334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial.
    Truong TM; Apfelbaum JL; Danahey K; Schierer E; Ludwig J; George D; House L; Karrison T; Shahul S; Anitescu M; Choksi A; Hartman S; Knoebel RW; van Wijk XMR; Yeo KJ; Meltzer DO; Ratain MJ; O'Donnell PH
    Anesth Analg; 2022 Nov; 135(5):929-940. PubMed ID: 35213469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
    Schwartz EJ; Issa AM
    Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of the current status of real-world pharmacogenomic testing: informed consent, patient education, and related practices.
    Pereira L; Haidar CE; Haga SB; Cisler AG; Hall A; Shukla SK; Hebbring SJ; Leary EJW
    Front Pharmacol; 2024; 15():1355412. PubMed ID: 38410134
    [No Abstract]   [Full Text] [Related]  

  • 59. Psychiatric pharmacists' perception on the use of pharmacogenomic testing in the mental health population.
    Shishko I; Almeida K; Silvia RJ; Tataronis GR
    Pharmacogenomics; 2015; 16(9):949-58. PubMed ID: 26100610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacists' Knowledge, and Insights in Implementing Pharmacogenomics in Saudi Arabia.
    Alhaddad ZA; AlMousa HA; Younis NS
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.